Trevor Martin

Dr. Trevor Martin co-founded Mammoth Biosciences with the mission to enable the next generation of CRISPR-based synthetic biology products across therapeutics and diagnostics. Areas of focus include a novel class of affordable, effective, and rapid CRISPR-enabled molecular diagnostics that allow individuals worldwide to better understand their health and novel families of nano-sized CRISPR proteins including Cas14 and CasPhi that can enable in-vivo editing and permanent genetic cures. Trevor earned his BA from Princeton University and his Ph.D. in Biology from Stanford. His scientific work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is a Malaria No More “10 to END” innovator.